INTRODUCTION
============

Interconnected with the central importance of the macromolecular structural scaffold, the dynamics or movements of structural elements play a key role in all biological processes. Electron paramagnetic resonance (EPR) spectroscopy can provide information on both the dynamics as well as the global structure of biological molecules ([@B1; @B2; @B3; @B4]). For such studies on nucleic acids, several nitroxide spin labels have been developed ([@B5; @B6; @B7; @B8; @B9; @B10; @B11]). Most of these reporters contain flexible linkers with one or more rotatable bonds between the nitroxide spin label and the nucleic acid. Flexible linkers introduce uncertainty in the measurement of dynamics, or determination of distances between two nitroxide spin labels due to movement of the probe independent of the nucleic acid. Therefore, we designed and synthesized the rigid nitroxide spin-labeled cytidine analog **Ç** (C-spin) for use in studies of the structure and dynamics of nucleic acids by EPR spectroscopy ([@B12]). The nitroxide moiety of this reporter can be reduced with a mild reducing reagent such as sodium sulfide (Na~2~S) to produce a fluorescent nucleoside (Ç^f^), which was used for detection of mismatches in DNA ([@B13],[@B14]). Therefore, both EPR and fluorescence spectroscopies can be used with the same spectroscopic label as illustrated in folding studies of the cocaine DNA aptamer ([@B15]) and dynamics of DNA hairpin loops ([@B16]). Pulsed electron--electron double resonance (PELDOR) has also been used to determine precise distances and angular orientations within **Ç**-labeled DNAs ([@B17],[@B18]). Thus, this bi-functional reporter allows for the study of nucleic acid structure and dynamics via the complementary spectroscopic techniques of fluorescence and EPR.

As with any reporter group used in biophysical experiments, it is important that the probe does not perturb the structure of the biological system of interest. If the reporter group is structurally perturbing, the results obtained from biophysical experiments would falsely report the nature of the macromolecule. Therefore, the effect of the reporter on the structure of the biopolymer must be carefully analyzed. Despite the widespread use of spectroscopic probes in biophysical studies, there are very few crystal structures containing covalently bound spectroscopic probes aside from 2-aminopurine for nucleic acids ([@B19; @B20; @B21]) and nitroxide spin labels for proteins ([@B22; @B23; @B24; @B25]). Obtaining a high-resolution crystal structure of a nucleic acid containing a spectroscopic probe remains challenging, and thus most researchers have relied on a variety of biophysical techniques to provide indirect evidence as to whether or not a probe alters the structure of the macromolecule of interest. For example, melting temperature analysis of DNAs containing **Ç** showed only subtle changes in the melting temperatures relative to unlabeled DNAs ([@B16]). In addition, EPR studies of dynamics ([@B12],[@B16]) and distance measurements ([@B18]) aligned well with predicted models. Despite these encouraging biophysical data, no direct structural evidence exists to demonstrate whether or not the reporter **Ç** is structurally perturbing, forms a proper base pair with deoxyguanosine and what may be the preferred conformation. Furthermore, one concern with regards to the structure of the spin-labeled nucleoside was the fact that the phenoxazine-derived nucleobase contains 16 π-electrons. This number of electrons in a cyclic π-system indicates antiaromaticity, which could result in non-planarity of the ring system. Because a bend in the nucleobase might affect the use of this probe for biophysical studies, we undertook a detailed analysis of its high-resolution structure.

Here we report a detailed crystallographic characterization of **Ç**. This analysis includes small molecule crystal structures of the **ç** nucleobase, which has been used for non-covalent spin labeling of nucleic acids containing an abasic site ([@B26]), and its phenoxazine analog ([@B1]) ([Figure 1](#F1){ref-type="fig"}) as well as a 1.7 Å resolution crystal structure of a decamer DNA duplex containing **Ç**. The high-resolution nucleic acid structure demonstrates that within the context of the nucleic acid, the nitroxide spin label **Ç** adopts a planar conformation while forming a standard three hydrogen bond base pair with deoxyguanosine. These results validate the interpretation of distance and orientation measurements between two **Ç** reporters described previously and provide the basis for further structural and dynamics studies on oligonucleotides with unknown folds. Figure 1.(**a**) Structures of phenoxazine-derived nitroxide spin labels **Ç** and **ç**, and the unmodified phenoxazine derivative **1**. The spin labels are shown base-paired with guanine (**G**), with hydrogen bonds indicated by dashed lines (**b**) Sequence and secondary structure of the duplex DNA used to obtain a high-resolution crystal structure of a **Ç**-containing DNA helix. dR = 2′-deoxyribose. ^2′OMe^U = 2′-O-methyluridine.

MATERIALS AND METHODS
=====================

Small molecule crystallization and structure determination
----------------------------------------------------------

The nitroxide spin-labeled nucleobase **ç** was prepared as previously described ([@B26]), and the synthesis of phenoxazine **1** is described in the [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1). Yellow crystals of the **ç** spin label were obtained by slow evaporation from ethanol. Yellowish-brown crystals of **1** were obtained by slow evaporation from 3:1 dichloromethane:methanol solution. Crystals of **ç** and **1** were mounted on a Rigaku MM007/Mercury X-ray diffractometer (confocal optics Mo Kα radiation, 0.71073 Å). X-ray diffraction experiments were performed at 93 K. Intensity data were collected using accumulated area detector frames spanning at least a hemisphere of reciprocal space for all structures. Data were integrated using Crystal Clear. All data were corrected for Lorentz, polarization and long-term intensity fluctuations. Absorption effects were corrected on the basis of multiple equivalent reflections. The structures were solved by direct methods. Hydrogen atoms bound to carbon were idealized. Structural refinements were obtained with full-matrix least-squares based on F2 by using the program SHELXTL ([@B27]). The theta(max) resolution of the small molecule structure of **1** was 27.52 and the theta(max) resolution of the small molecule structure of **ç** was 25.3. Figure 2.Small molecule crystal structures of (**a**) phenoxazine (1) and (**b**) the nitroxide spin-labeled nucleobase **ç**.

Density function theory calculations
------------------------------------

Density function theory (DFT) calculations on the spin-labeled nucleobase **ç** were performed with the B3LYP functional, the 6-31G\* basis set and unrestricted spin-wave functions using Gaussian03 ([@B28]). To obtain a geometry optimized structure and single point energy for the bent spin label, the atoms of the spin label's phenoxazine moiety were frozen to the position obtained from the small molecule crystal structure and hydrogen atoms were added to the vacant positions. The constraints on the phenoxazine moiety were then relaxed to obtain the energy optimized structure and single point energy of the unbent spin label. The vibrational frequencies for both geometry-optimized structures were all positive, indicating the structures represent an energy minimum. The single point energy for the bent and planar spin label was −2 795 044.283 kJ/mol and −2 795 045.594 kJ/mol respectively. The unbent structure is 1.31 kJ/mol less in energy. The frequency for the bending motion around the oxazine linkage is 18.8 and 28.3 cm^-1^ for the planar and the bent conformation, respectively.

DNA crystallization and structure determination
-----------------------------------------------

A 10 nt-long DNA containing **Ç** at position 2 and 2′-*O*-methyl U at position 6 ([Figure 1](#F1){ref-type="fig"}b) was prepared via solid-phase chemical synthesis as described previously ([@B12],[@B16]). The decamer duplex DNA sample containing the nitroxide spin-labeled nucleotide **Ç** was crystallized as described for a similar phenoxazine-containing cytosine analog ([@B29]). Crystals were grown at 16°C using the sitting drop vapor diffusion method from 0.4 µl of DNA (2.4 mM) mixed with 0.4 µl of 10% (±)-2-methane-2,4-pentanediol (MPD), 40 mM sodium cacodylate pH 6.0, 12 mM spermine·HCl, 80 mM NaCl, 12 mM KCl, 12 mM MgCl~2~ and equilibrated against a reservoir of 35% MPD. Crystals of the 10 nt-long DNA containing 2′-*O*-methyl U and **Ç** grew over several months. Most crystals grew as clusters, although one drop contained two single crystals ([Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)). A single crystal was vitrified by plunging into liquid nitrogen and a data set was collected using a Rigaku FR-E^+^ SuperBright rotating anode X-ray generator with VariMax HF optics and a Saturn 944^+^ CCD detector. The crystal diffracted beyond the resolution limits of the detector at the minimum detector distance ([Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)), and thus a 2θ swing of −15° was used to enhance the resolution limits given the in house X-ray system. Nevertheless, the crystal diffracted beyond the resolution limits of the in house X-ray detection system, as determined by the strong signal in the highest resolution bin (*I*/σ = 20; [Table 1](#T1){ref-type="table"}). The data were reduced with XDS and XSCALE ([@B30]). The structure was solved by molecular replacement using PHASER ([@B31]) from the CCP4 suite ([@B32]) and contained two DNA molecules (i.e. a self-complementary duplex) in the asymmetric unit. The structure was refined with numerous reiterative rounds of refinement in REFMAC ([@B33]) and manual building in Coot ([@B34]). The final crystallographic model was produced after two additional rounds of refinement in Phenix ([@B35]) which utilized a CIF file containing the modified nucleotide linkage definitions generated using the program Jligand (G.N. Murshudov *et al*., unpublished data). Table 1.Crystallographic statistics for a DNA containing **Ç**Space group*P*2~1~2~1~2~1~Unit cella = 24.71 Å, b = 44.55 Å, c = 45.94 Å; α = β = γ = 90°Vm1.95 Å^3^/Da^a^Solvent content57.4%Resolution50--1.7 Å (1.74--1.70 Å)[^b^](#TF2){ref-type="table-fn"}I/σ54.0 (20.0)Completeness94.3% (82.9%)*R*~merge~0.022 (0.070)Multiplicity8.4 (6.4)Reflections5613 (354)Refinement *R*~cryst~15.9% (0.138) *R*~free~19.5% (0.218) Mean *B*-factor14.5 Å^2^Number of atoms    DNA436    Solvent83    Total519[^1][^2]

RESULTS AND DISCUSSION
======================

Small molecule crystal structures were determined for the **ç** nucleobase as well as the phenoxazine analog **1** ([Figure 2](#F2){ref-type="fig"}a and [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)). The phenoxazine nucleobase **1** adopts a planar conformation with almost no bend at the oxazine linkage between the cytosine and benzene rings ([Figure 2](#F2){ref-type="fig"}a). In contrast, **ç** adopts a non-planar geometry with a bend of ∼20° at the oxazine linkage between the cytosine and benzene rings ([Figure 2](#F2){ref-type="fig"}b and [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)). In order to rationalize the conformational differences of the phenoxazine moiety, DFT calculations have been performed on **ç** in the bent conformation as found in the small molecule crystal structure and on **ç** in the planar conformation as found in the small molecule crystal structure of **1**. These calculations revealed that the bent form is only 1.31 kJ/mol higher in energy than the planar form and that all vibrational frequencies for both conformations are positive. Thus, both conformations are similar energy minima or might actually belong to the same energy minimum. This is supported by the finding that the frequencies for the bending motion differ by only 10 cm^−1^ (18 and 28 cm^−1^ for the planar and bent conformation, respectively). Taken together, we interpret these results as both conformations belonging to the same energy minimum with a low energy bending motion around the oxazine linkage. Because bending the phenoxazine moiety costs little energy, the surrounding environment such as crystal packing can drive it into either conformation. This raises the question as to whether **ç** is bent or planar when incorporated into an oligonucleotide structure. Thus, we proceeded to obtain a high-resolution structure of a DNA containing **Ç** to establish the preferred conformation of **Ç** within the context of a nucleic acid.

Initially, we selected two previously reported duplex DNA crystal forms, one A-form ([@B36]) and one B-form ([@B37]), for incorporation of **Ç** and subsequent crystallographic structure determination. Each of these crystal forms was chosen because it contained a cytosine residue that in principle had sufficient space within the crystal lattice to accommodate replacement with **Ç**. We incorporated **Ç** at positions 4 or 6 of the self-complementary octamer A-form duplex DNA as well as position 9 of the self-complementary dodecamer B-form duplex DNA. Despite producing large, well diffracting crystals using unmodified DNA samples, we observed only thin plate crystals that were unsuitable for structure determination using DNA samples containing **Ç** (data not shown). Therefore, we sought a different crystal form for incorporation of **Ç** and structural characterization.

Egli *et al.* ([@B38]) reported crystal structures of an A-form decamer DNA duplex with either cytosine or the phenoxazine-derived cytosine analog 'G-clamp' ([@B29]). These crystal structures contain a 2′-*O*-methoxymethyl T at position 6 that promotes formation of A-form DNA in solution rather than B-form, which is standard for DNA. To our knowledge, the 2′-*O*-methoxymethyl T phosphoramidite is not commercially available, and thus we first produced crystals with a C at position 2 and a 2′-*O*-methyl U at position 6. These crystals diffracted X-rays to better than 2.3 Å resolution in house (data not shown). Next, a DNA sample was prepared with the nitroxide spin label **Ç** incorporated into position 2 and a 2′-*O*-methyl U at position 6 ([Figure 1](#F1){ref-type="fig"}b) and resulted in a crystal from which we determined a 1.7 Å resolution crystal structure ([Figure 3](#F3){ref-type="fig"}, [Table 1](#T1){ref-type="table"} and [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)). Crystals suitable for structure determination failed to grow from a sample containing **Ç** at position 2 with a dT at position 6 (i.e. no 2′-*O*-methyl). EPR spectra of these two **Ç-**containing samples, one with a 2′-*O*-methyl U at position 6 that should be A-form in solution and one with a dT at position 6 that should be B-form in solution, were found to be nearly identical ([Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)). Thus, there is likely to be little difference in the mobility of the probe in comparison of A- and B-form DNA in solution. Inspection of the electron density maps from our 1.7 Å resolution structure obtained from the DNA sample containing **Ç** at position 2 and a 2′-*O*-methyl U at position 6 clearly showed the 2′-*O*-methyl group of U6 ([Figure 3](#F3){ref-type="fig"} and [Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)). Figure 3.Overall crystal structure of a DNA containing **Ç**. (**a**) Stick figure representation of an A-form duplex DNA crystal structure containing **Ç** solved at 1.7 Å resolution. For clarity, **Ç** is shown in light blue carbon backbone and the remainder of the DNA is shown in gray carbon backbone. (**b**) Final crystallographic model containing waters overlaid with the 2\|*F*~o~\|−\|*F*~c~\| electron density map shown in blue mesh and contoured at 1.0 σ.

The 1.7 Å resolution crystal structure of the decamer duplex DNA containing **Ç** at position 2 was initially refined with an abasic site at this position. The resulting omit \|*F*~o~\|−\|*F*~c~\| electron density map showed unambiguous electron density for the **Ç** nucleobase ([Figure 4](#F4){ref-type="fig"}a). The simulated-annealing omit 2\|*F*~o~\|−\|*F*~c~\| electron density map calculated with phases from the refined model was of excellent quality and revealed unambiguously that **Ç** forms a standard base pair with dG9 of the opposite strand with three ∼2.8 Å long hydrogen bonds ([Figure 4](#F4){ref-type="fig"}b and c). The structure of the nucleic acid helix containing **Ç** superimposes closely on a previously reported structure containing a deoxycytidine residue at this position ([@B38]) ([Figure 5](#F5){ref-type="fig"}), indicating that **Ç** does not perturb the DNA structure relative to a standard deoxycytidine residue. EPR spectroscopic analysis showed that **Ç** had decreased mobility in duplex DNA relative to single-stranded ([@B12],[@B16]) or bulged ([@B39]) sites and could be used to measure single strand to duplex transitions during folding ([@B15]), implying **Ç** forms a base pair with dG. Furthermore, thermal denaturation experiments showed that the **Ç**•dG pairing had a similar melting temperature to a dC•dG pair, but showed a decrease in the melting temperature of 10--15°C when **Ç** was paired with dA, dT or dC ([@B12]). Combined with the EPR spectroscopy and thermal denaturation results, the high-resolution crystal structure described here shows that **Ç** is a non-perturbing cytosine analog that forms a Watson--Crick base pair with dG as designed. Figure 4.Examination of the nitroxide spin-labeled nucleotide **Ç** within the high-resolution DNA crystal structure. (**a**) Side- and top-down views of **Ç** superimposed with the \|*F*~o~\|−\|*F*~c~\| omit electron density map shown in green mesh contoured at 3.0 σ. (**b**) Side view of **Ç** superimposed with the 2\|*F*~o~\|−\|*F*~c~\| electron density map, shown in blue mesh contoured at 1.0 σ. (**c**) Top-down view of the base pair formed by deoxyguanosine and **Ç** superimposed with the 2\|*F*~o~\|−\|*F*~c~\| electron density map shown in blue mesh contoured at 1.0 σ. Hydrogen bonds are depicted as dashed lines. Figure 5.Overlay of the 1.7 Å resolution crystal structure of a DNA containing the nitroxide spin-labeled deoxycytosine analog **Ç** (gray carbon backbone) with a crystal structure containing deoxycytosine at the same position (PDB ID 1DPL, green carbon backbone) ([@B38]).

The crystal structure shows that within the context of a nucleic acid, **Ç** adopts a planar geometry ([Figure 4](#F4){ref-type="fig"}b) rather than the bent geometry observed in the crystal structure of **ç** ([Figure 2](#F2){ref-type="fig"}b). At the oxazine linkage, N4 of **Ç** is involved in a 2.9 Å hydrogen bond with dG9 of the opposite strand and O5 does not form hydrogen bonds with any water molecules, but rather packs 3.7 Å away from O2P of the **Ç** phosphate and also C3′ of residue G1. This is similar to what was observed for the small molecule crystal structure of phenoxazine **1** alone or the phenoxazine-derived 'G-clamp' modified nucleoside ([@B29]). At the current resolution limits, no water-mediated interactions were observed off the nitroxide of **Ç** in the major groove. However, if one extends the model 5′ of dG1, it is possible that the nitroxide could make water mediate mediated interactions with the phosphate or base two residues away on the 5′ side of **Ç**. If that residue were a purine, we speculate that additional packing interactions may be observed with the nitroxide ring. Interestingly, examination of the high-resolution DNA crystal structure shows that the average *B*-factor of the pyrimidine ring (12.9 Å^2^) is lower than either the benzene ring (19.3 Å^2^) or the nitroxide ring (25.2 Å^2^). This demonstrates greater static or dynamic disorder of the nitroxide ring relative to the pyrimidine ring, which could be reflective of the bending motion observed in DFT calculations for the free label **ç**. Alternatively, the increased *B*-factors could be reflective of rigid body motion of the entire nucleobase relative to the sugar-phosphate backbone. Nevertheless, the preferred conformation of the nucleobase of **Ç** in DNA is planar; the amplitude of the bending motion is clearly more restricted within the DNA duplex than observed in the crystal structure of the free label **ç**, presumably due to the benefit of van der Waals packing interactions with the 5′ deoxyguanosine base ([Supplementary Data and below](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)). Although the phenoxazine ring system is formally antiaromatic, it has been shown with 20 and 24 π electron N,N-dihydrodiazatetracenes by X-ray crystallography, cyclic voltammetry and nucleus independent chemical shift calculations that they have reduced aromaticity, rather than antiaromaticity ([@B40]).

Crystal structures with other phenoxazine-containing compounds include those of the antibiotic actinomycin, which reveal a slight bend at the oxazine linkage ([@B41]), and of actinomycin bound to DNA which reveal a planar conformation of the phenoxazine moiety ([@B42; @B43; @B44]). We note that there is significant π-stacking interaction of the phenoxazine component of **Ç** with dG1 ([Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr015/DC1)), as was observed in the G-clamp crystal structure ([@B29]) and is consistent with π-stacking in the actinomycin-DNA crystal structures ([@B42; @B43; @B44]). Previously, we examined the melting temperature of a series of DNAs to determine the effect of **Ç**, and in some cases, a +5°C shift in the melting temperature of duplex DNAs containing **Ç** has been observed ([@B16]), which could be consistent with the π-stacking observed in the crystal structure presented here and with other phenothiazine- and phenoxazine-labeled DNA structures ([@B45],[@B46]). Increased melting temperatures do not necessarily correlate with π-stacking, but could be due to simple van der Waals packing as observed in crystal structures of a modified deoxycytosine base with a non-aromatic two-ring system ([@B47]). Given that the antibiotic actinomycin and **ç**/**Ç** are both observed in planar and bent forms and our DFT calculations show that the bent and planar conformations of **ç** are similar in energy and frequency, we predict that other phenoxazine-derived molecules would exhibit a similar general pattern. In summary, the high-resolution crystal structure of a DNA containing **Ç** showed that the spin label adopts a planar geometry with indicators of modest mobility at the oxazine ring, consistent with small molecule crystal structures, DFT geometry calculations and previously published crystal structures of molecules containing phenoxazine-based compounds, such as actinomycin.

Only a handful of crystal structures of biological macromolecules containing spectroscopic probes have hitherto been reported. We have performed a detailed crystallographic analysis of the nitroxide spin-labeled deoxycytosine analog **Ç**. Consistent with previous EPR and fluorescence spectroscopic and thermal stability results, the results presented here demonstrate that **Ç** is a non-perturbing cytosine analog that forms a Watson--Crick base pair with dG. These results increase the accuracy and interpretation of distance and orientation measurements made with this spectroscopic probe and provide a benchmark for structural characterization of spectroscopic probes.
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[^1]: ^a^Matthews co-efficient and solvent content calculated based on a predicted duplex DNA MW of 6494 Da.

[^2]: ^b^Values in parenthesis indicated highest of 20 resolution bins for data reduction and highest of four resolution bins for refinement.
